News Archive

2015

June

Media Release / Jun 29, 2015

Novartis deepens its industry leading pipeline with acquisition of Spinifex Pharmaceuticals, Inc.

Read More
Media Release / Jun 29, 2015

Novartis announces publication in The Lancet showing sustained efficacy with secukinumab over one year in psoriatic arthritis patients

Read More
Media Release / Jun 26, 2015

Novartis drug Farydak® recommended by CHMP for EU approval to treat multiple myeloma, providing patients a new mechanism of action

Read More
Media Release / Jun 18, 2015

Sandoz announces US launch of Glatopa(TM), the first generic competitor to Copaxone® 20mg

Read More
Media Release / Jun 18, 2015

Novartis highlights strong innovation momentum at its second Meet Novartis Management investor day

Read More
Media Release / Jun 16, 2015

Alcon receives European approval for new trifocal presbyopia-correcting intraocular lens for patients undergoing cataract surgery

Read More
Media Release / Jun 13, 2015

Novartis presents new data from large European study reinforcing the benefit of first-line Tasigna® in newly-diagnosed patients with CML

Read More
Media Release / Jun 13, 2015

Novartis announces data show majority of patients with polycythemia vera treated with Jakavi® achieved long-term disease control

Read More
Media Release / Jun 12, 2015

Novartis data at EHA show increased PFS benefit of Farydak® in new subgroup of patients with previously treated multiple myeloma

Read More
Media Release / Jun 12, 2015

Novartis drug Arzerra® improved median progression-free survival by 54% in patients with relapsed chronic lymphocytic leukemia

Read More